Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast

被引:21
作者
Karayiannakis, AJ
Bastounis, EA
Chatzigianni, EB
Makri, GG
Alexiou, D
Karamanakos, P
机构
[1] UNIV ATHENS, SCH MED, DEPT SURG 1, GR-11527 ATHENS, GREECE
[2] UNIV ATHENS, SCH MED, PROPAEDEUT DEPT SURG 1, RES LAB, GR-11527 ATHENS, GREECE
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 1996年 / 22卷 / 06期
关键词
oestrogen receptor; immunohistochemistry; ductal carcinoma in situ; breast cancer;
D O I
10.1016/S0748-7983(96)92242-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of oestrogen receptor (ER) protein in invasive carcinoma of the breast and its clinical significance has been extensively evaluated, Little information is available regarding ER expression in ductal carcinoma in situ (DCIS), In this study, 46 formalin-fixed, paraffin-embedded tissue specimens of mammographically detected DCIS were evaluated immunohistochemically for the presence of ER using specific monoclonal antibodies against ER (ER-ICA Abbott Lab), The associations between ER expression and histological type, degree of differentiation and patient menopausal status were evaluated, Positive ER staining was present in 72% of cases, Non-comedo types of DCIS were more frequently ER-positive than comedocarcinoma, ER-positive tumours were inversely correlated with the presence of nuclear pleomorphism, The incidence of ER in pre-menopausal and post-menopausal women was similar, In conclusion, ER expression is present in a considerable percentage of DCIS, and ER-positivity is associated with the degree of differentiation and non-comedo carcinoma variants.
引用
收藏
页码:578 / 582
页数:5
相关论文
共 31 条
[11]  
DANIELL HW, 1988, CANCER, V61, P1237, DOI 10.1002/1097-0142(19880315)61:6<1237::AID-CNCR2820610630>3.0.CO
[12]  
2-F
[14]   LUMPECTOMY COMPARED WITH LUMPECTOMY AND RADIATION-THERAPY FOR THE TREATMENT OF INTRADUCTAL BREAST-CANCER [J].
FISHER, B ;
COSTANTINO, J ;
REDMOND, C ;
FISHER, E ;
MARGOLESE, R ;
DIMITROV, N ;
WOLMARK, N ;
WICKERHAM, DL ;
DEUTSCH, M ;
ORE, L ;
MAMOUNAS, E ;
POLLER, W ;
KAVANAH, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1581-1586
[15]   A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J].
FISHER, B ;
COSTANTINO, J ;
REDMOND, C ;
POISSON, R ;
BOWMAN, D ;
COUTURE, J ;
DIMITROV, NV ;
WOLMARK, N ;
WICKERHAM, DL ;
FISHER, ER ;
MARGOLESE, R ;
ROBIDOUX, A ;
SHIBATA, H ;
TERZ, J ;
PATERSON, AHG ;
FELDMAN, MI ;
FARRAR, W ;
EVANS, J ;
LICKLEY, HL ;
KETNER, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :479-484
[16]   ESTROGEN-RECEPTORS IN BENIGN EPITHELIAL LESIONS AND INTRADUCT CARCINOMAS OF THE BREAST - AN IMMUNOHISTOLOGICAL STUDY [J].
GIRI, DD ;
DUNDAS, SAC ;
NOTTINGHAM, JF ;
UNDERWOOD, JCE .
HISTOPATHOLOGY, 1989, 15 (06) :575-584
[17]   MONOCLONAL-ANTIBODIES AS PROBES FOR ESTROGEN-RECEPTOR DETECTION AND CHARACTERIZATION [J].
GREENE, GL ;
JENSEN, EV .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1982, 16 (03) :353-359
[18]  
HELLIN HJ, 1989, CANCER, V63, P1761
[19]  
KUTE TE, 1981, CANCER RES, V41, P3524
[20]  
MASOOD S, 1989, ARCH PATHOL LAB MED, V113, P26